Human NK cells: From development to effector functions by Arosh Shavinda Perera Molligoda Arachchige

“…NK cells are the major lymphocyte subset of the innate immune system that mediates antiviral and anti-tumor responses. …”
Get full text

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas by Changqing Pan, You Zhai, Guanzhang Li, Tao Jiang, Tao Jiang, Tao Jiang, Tao Jiang, Wei Zhang, Wei Zhang, Wei Zhang, Wei Zhang

“…For example, NK cell-based immunotherapy causes minimal graft-versus-host disease. …”
Get full text

Epigenetic regulation of NK cell differentiation and effector functions by Frank eCichocki, Frank eCichocki, Jeffrey S Miller, Stephen K Anderson, Stephen K Anderson, Yenan T Bryceson

Subjects: Get full text

Aggressive NK Cell Leukemia: Current State of the Art by Siba El Hussein, L. Jeffrey Medeiros, Joseph D. Khoury

Subjects: Get full text

Biomarkers as targets for CAR-T/NK cell therapy in AML by Ruonan Shao, Zijian Li, Honglei Xin, Suyu Jiang, Yilin Zhu, Jingan Liu, Rong Huang, Kailin Xu, Xiaofeng Shi

“…T cells and natural killer (NK) cells engineered with chimeric antigen receptors (CARs) that target antigens associated with AML have recently been produced and are currently being tested in both pre-clinical and clinical settings. …”
Get full text

The Role of microRNAs in NK Cell Development and Function by Arash Nanbakhsh, Subramaniam Malarkannan

Subjects: Get full text

1538 Cytokine checkpoint discovery in human NK cells by Nicholas D Huntington, Iva Nikolic, Joe Cursons, Benjamin Shields, Stephane Chappaz

The Impact of Obesity on T and NK Cells after LVAD Implantation by Eva Katharina Messer, Anna Lassia Meyer, Kristin Klaeske, Franz Sieg, Sandra Eifert, Dominik Schmiedel, Josephina Haunschild, Khalil Jawad, Diyar Saeed, Lea Hildebrandt, Michael Andrew Borger, Maja-Theresa Dieterlen

“…Further, obese patients showed an increase in the percentage of CD57+ NK cells after 6 and 12 months (p = 0.01) of treatment, higher proportions of CD56bright NK cells (p = 0.01), and lower proportions of CD56dim/neg NK cells (p = 0.03) 3 months after LVAD implantation than normal-weight patients. …”
Get full text

Signatures of human NK cell development and terminal differentiation by Merlin eLuetke-Eversloh, Monica eKillig, Chiara eRomagnani

Subjects: “…NK cells…”
Get full text

NK cell inflammation in the clinical outcome of colorectal carcinoma by Andrea eCoppola, Roberto eArriga, Davide eLauro, Maria Ilaria eDel Principe, Francesco eBuccisano, Luca eMaurillo, Patrizia ePalomba, Adriano eVenditti, Giuseppe eSconocchia

Subjects: Get full text

Editorial: Molecular and Cellular Pathways in NK Cell Development by Ewa Sitnicka, Yenan Bryceson, Yenan Bryceson, Aharon G. Freud, Aharon G. Freud, Emily M. Mace

Subjects: “…NK cells…”
Get full text

NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development by Calum Forrest, Ariane Gomes, Matthew Reeves, Victoria Male

“…Natural killer (NK) cells are innate lymphoid cells that recognize and eliminate virally-infected and cancerous cells. …”
Get full text

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies by Hansol Lee, Inês Pires Da Silva, Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long, James S. Wilmott

“…Natural killer (NK) cells are a key component of an innate immune system. …”
Get full text

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications by Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, Stefano Baldoni, Valerio Guarente, Andrea Marra, Erica Dorillo, Chiara Rompietti, Francesco Maria Adamo, Loredana Ruggeri, Mauro Di Ianni, Emanuela Rosati

Subjects: Get full text

NK cell defects: implication in acute myeloid leukemia by Selma Z. D’Silva, Meenakshi Singh, Meenakshi Singh, Andrea S. Pinto

“…Recently, different Natural Killer cell therapies have been implicated in treating AML, such as the adoptive NK cell transfer, Chimeric antigen receptor-modified NK (CAR-NK) cell therapy, antibodies, cytokine, and drug treatment. …”
Get full text

OPTIMIZING INTRACELLULAR SIGNALING DOMAINS FOR CAR-NK CELLS by J.T.C. Azevedo, R.N. Silvestre, A.M. Pessoni, K.C.R. Malmegrim, D.T. Covas, V. Picanço-Castro

Get full text

The role of NK cells in selectin-dependent tumor suppression by Sobolev, Olga, Ph. D. Massachusetts Institute of Technology

Get full text

NK cell compartment in patients with coronary heart disease. by Hak, Ł, Myśliwska, J, Wieckiewicz, J, Szyndler, K, Trzonkowski, P, Siebert, J, Myśliwski, A

“…Thus, the main aim of our study was to determine NK cell compartment in patients with CHD undergoing coronary artery by-pass grafting. …”

Ligand dimensions are important in controlling NK-cell responses. by Brzostek, J, Chai, J, Gebhardt, F, Busch, D, Zhao, R, Van Der Merwe, P, Gould, K

“…Importantly, H60a elongation did not affect NKG2D binding, as determined by soluble NKG2D tetramer staining, and by examining NK-cell target cell conjugate formation. CHO cells are efficient at activating NK cells from C57BL/6 mice, and expression of a single chain form of H-2K(b), a ligand for the mouse inhibitory receptor Ly49C, strongly inhibited such activation of Ly49C/I positive NK cells. …”

Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations by David S.J. Allan, Chuanfeng Wu, Ryland D. Mortlock, Mala Chakraborty, Katayoun Rezvani, Jan K. Davidson-Moncada, Cynthia E. Dunbar, Richard W. Childs

Subjects: Get full text